2026 NPPES data Otolaryngology Physician NPI 1659366318 MD
Verify on CMS →

JOEL JAFFE, MD

Otolaryngology Physician in LANGHORNE, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
614
Medicare Part D claims · 243 beneficiaries · Otolaryngology Physician avg: 509
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.7203/100
▲ 9 pts above national avg 83.1 · [object Object]
Industry payments
$125.5
6 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JOEL JAFFE, MD reported a CMS MIPS final score of 91.7203/100 — above the 83.1 national average — and filed 614 Medicare Part D claims in 2023.

91.7203/100
MIPS score · +9 vs avg
614
Part D claims, 2023
89%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOEL JAFFE, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

92 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JOEL JAFFE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JOEL JAFFE, MD?

High performer (top quartile)

NPI registry status

Active

Issued 09/19/2005

NPI 1659366318

Primary specialty

Otolaryngology Physician

Mid-sized

10,895 US NPIs in this specialty

Medicare Part D claims

614 21% vs specialty avg

2023 prescription claims

Specialty avg: 509

MIPS final score

91.7203/100 8.6203% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Pennsylvania

How Otolaryngology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Otolaryngology Physician share within Pennsylvania

1. Otolaryngology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngology Physician share within Pennsylvania

Medicare quality performance — MIPS

JOEL JAFFE, MD's 2023 MIPS final score plotted against the Otolaryngology Physician national average

High performer (top quartile)
MIPS Final Score
91.7203/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Otolaryngology Physician) — 91.7203/100 vs national avg 83.1

0%100%National avg83%91.7%
MIPS final score (Otolaryngology Physician) — 91.7203/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOEL JAFFE, MD appears in the CMS NPPES registry as a Otolaryngology Physician provider holding MD credentials at 400 MIDDLETOWN BLVD, LANGHORNE, PA, 19047, with a listed phone of (215) 750-7300. NPI 1659366318 was issued on 09/19/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what JAFFE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 614 prescription claims written by this provider, covering 243 Medicare beneficiaries and totaling roughly $41K in drug spend, split 11% brand-name and 89% generic by claim count, with an opioid prescribing rate of 1.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.7203/100 for the 2023 performance year (Quality 83.4405), compared with the national average of 83.1.

Otolaryngology Physician is a mid-sized specialty nationwide, with 10,895 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

400 MIDDLETOWN BLVD
LANGHORNE, PA 19047

Provider Details

NPI 1659366318
Specialty Otolaryngology Physician
Credentials MD
Gender Male
NPI Issued 09/19/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.7203
Final Score
Avg: 83.1
83.4405
Quality

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JOEL JAFFE, MD. Source: openpaymentsdata.cms.gov.

Total received

$125

Largest payer

Optinose US, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to JOEL JAFFE, MD. To verify JOEL JAFFE, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

JOEL JAFFE, MD — brand share 11.0%
Specialty average (est.)

11% brand-name claims vs 89% generic, on 614 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

614
Total Claims
$41K
Total Drug Cost
243
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
898
Total Day Supply
21,152
Brand vs Generic
11% brand / 89% generic
Brand Drug Cost
$31K
Generic Drug Cost
$10K
Opioid Claims
11 (1.8% rate)
Antibiotic Claims
128

Patient Demographics

Average Patient Age
73.7 years
Avg HCC Risk Score
1.13
Gender Split
60% female / 40% male
Age Distribution
<65: 14, 65-74: 117, 75-84: 87, 85+: 25

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JOEL JAFFE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisone
88
Azelastine Hcl
48
Ipratropium Bromide
43
Omeprazole
38
Cephalexin
33
Fluticasone Propionate
33
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
30
Ciprofloxacin-Dexamethasone
Ciprofloxacin Hcl/Dexameth
19
Triamterene-Hydrochlorothiazid
Triamterene/Hydrochlorothiazid
19
Ozempic
Semaglutide
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngology Physician Overview

How JOEL JAFFE, MD fits within the Otolaryngology Physician landscape nationally.

10,895
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
509
Avg Claims per Provider

JOEL JAFFE, MD's 614 claims are above the specialty average of 509.

Nearby Otolaryngology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as JAFFE.

Compare Otolaryngology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOEL JAFFE, MD's specialty?
JOEL JAFFE, MD specializes in Otolaryngology Physician and practices in LANGHORNE, Pennsylvania. Credentials: MD.
How much does JOEL JAFFE, MD prescribe under Medicare Part D?
In 2023, JOEL JAFFE, MD wrote 614 Medicare Part D claims totaling $41K in drug costs for 243 beneficiaries.
What is JOEL JAFFE, MD's Medicare quality score?
JOEL JAFFE, MD has a CMS MIPS Final Score of 91.7203/100 (Quality: 83.4405). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JOEL JAFFE, MD located?
JOEL JAFFE, MD is located at 400 MIDDLETOWN BLVD, LANGHORNE, PA, 19047. Phone: (215) 750-7300.
What is JOEL JAFFE, MD's NPI number?
JOEL JAFFE, MD's National Provider Identifier (NPI) is 1659366318, issued on 09/19/2005.
Does JOEL JAFFE, MD prescribe more brand-name or generic drugs?
JOEL JAFFE, MD's prescribing is 11% brand-name and 89% generic drugs by claim count, with $31K in brand drug costs.
Does JOEL JAFFE, MD prescribe opioids?
Yes, JOEL JAFFE, MD had 11 opioid claims in 2023 with an opioid prescribing rate of 1.8%.
How many Otolaryngology Physician providers are there in the US?
There are 10,895 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 509 Medicare Part D claims per year.
What drugs does JOEL JAFFE, MD prescribe most often?
Based on 2023 Medicare Part D data, JOEL JAFFE, MD's most frequently prescribed drugs include Prednisone, Azelastine Hcl, Ipratropium Bromide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOEL JAFFE, MD accept Medicare?
JOEL JAFFE, MD appears in CMS Medicare data with 614 Part D claims and 243 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOEL JAFFE, MD's credentials?
JOEL JAFFE, MD's NPI is 1659366318 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology